Skip to content
777 Sourcing.

Capability

non-viral gene therapy delivery

Suppliers
1
States & provinces
1
Countries
1

1 non-viral gene therapy delivery supplier across 1 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

KINEA BIO INC

MUKILTEO, WA

Kinea Bio is a Seattle-based biotechnology company founded in 2020 by scientific leaders in the neuromuscular disease space. It is developing next-generation genetic medicine for neuromuscular diseases, including Duchenne Muscular Dystrophy (DMD), dysferlinopathy, and DM1, using AAV-gene therapy approaches such as its Split-Intein Dual-AAV approach and SIMPLI-GT™ technology.

AAV-gene therapygene therapySIMPLI-GT™ technologySplit-Intein Dual-AAV approach

Compiled from public sources

Related capabilities

Other processes offered by the shops that list non-viral gene therapy delivery.

Browse all capabilities